Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.
Howes OD, Rogdaki M, Findon JL, Wichers RH, Charman T, King BH, Loth E, McAlonan GM, McCracken JT, Parr JR, Povey C, Santosh P, Wallace S, Simonoff E, Murphy DG. Howes OD, et al. Among authors: parr jr. J Psychopharmacol. 2018 Jan;32(1):3-29. doi: 10.1177/0269881117741766. Epub 2017 Dec 14. J Psychopharmacol. 2018. PMID: 29237331 Free PMC article. Review.
Systematic review of tools to measure outcomes for young children with autism spectrum disorder.
McConachie H, Parr JR, Glod M, Hanratty J, Livingstone N, Oono IP, Robalino S, Baird G, Beresford B, Charman T, Garland D, Green J, Gringras P, Jones G, Law J, Le Couteur AS, Macdonald G, McColl EM, Morris C, Rodgers J, Simonoff E, Terwee CB, Williams K. McConachie H, et al. Among authors: parr jr. Health Technol Assess. 2015 Jun;19(41):1-506. doi: 10.3310/hta19410. Health Technol Assess. 2015. PMID: 26065374 Free PMC article.
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1.
Parellada M, San José Cáceres A, Palmer M, Delorme R, Jones EJH, Parr JR, Anagnostou E, Murphy DGM, Loth E, Wang PP, Charman T, Strydom A, Arango C. Parellada M, et al. Among authors: parr jr. Front Psychiatry. 2021 Aug 24;12:701729. doi: 10.3389/fpsyt.2021.701729. eCollection 2021. Front Psychiatry. 2021. PMID: 34504446 Free PMC article.
Parent-mediated social communication therapy for young children with autism (PACT): long-term follow-up of a randomised controlled trial.
Pickles A, Le Couteur A, Leadbitter K, Salomone E, Cole-Fletcher R, Tobin H, Gammer I, Lowry J, Vamvakas G, Byford S, Aldred C, Slonims V, McConachie H, Howlin P, Parr JR, Charman T, Green J. Pickles A, et al. Among authors: parr jr. Lancet. 2016 Nov 19;388(10059):2501-2509. doi: 10.1016/S0140-6736(16)31229-6. Epub 2016 Oct 25. Lancet. 2016. PMID: 27793431 Free PMC article.
The Association Between Child and Family Characteristics and the Mental Health and Wellbeing of Caregivers of Children with Autism in Mid-Childhood.
Salomone E, Leadbitter K, Aldred C, Barrett B, Byford S, Charman T, Howlin P, Green J, Le Couteur A, McConachie H, Parr JR, Pickles A, Slonims V; PACT Consortium. Salomone E, et al. Among authors: parr jr. J Autism Dev Disord. 2018 Apr;48(4):1189-1198. doi: 10.1007/s10803-017-3392-x. J Autism Dev Disord. 2018. PMID: 29177606 Free PMC article.
Paediatric Autism Communication Therapy-Generalised (PACT-G) against treatment as usual for reducing symptom severity in young children with autism spectrum disorder: study protocol for a randomised controlled trial.
Green J, Aldred C, Charman T, Le Couteur A, Emsley RA, Grahame V, Howlin P, Humphrey N, Leadbitter K, McConachie H, Parr JR, Pickles A, Slonims V, Taylor C; PACT-G Group. Green J, et al. Among authors: parr jr. Trials. 2018 Sep 21;19(1):514. doi: 10.1186/s13063-018-2881-3. Trials. 2018. PMID: 30241574 Free PMC article.
203 results